Patriot Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Patriot Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-77,402	Closed	-$4.74M	–	83
2017 Q4	$4.74M	Buy	77,402 +1,119	+1%	+$70K	0.67%	54
2017 Q3	$4.86M	Buy	76,283 +381	+0.5%	+$22.2K	0.79%	46
2017 Q2	$4.23M	Buy	75,902 +2,642	+4%	+$144K	0.71%	53
2017 Q1	$3.98M	Buy	+73,260	New	+$4.02M	0.64%	53

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Wealth Management's BMY Position: Q1 2018 in Review

Patriot Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 77,402 shares — an estimated $4.74M sold.

Patriot Wealth Management first reported a position in BMY in Q1 2017 and held it in 4 quarters. The position peaked at $4.86M in Q3 2017. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Patriot Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
Patriot Wealth Management sold 77,402 Bristol-Myers Squibb shares in Q1 2018, an estimated $4.74M.
Patriot Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 4 quarters.
Patriot Wealth Management's Bristol-Myers Squibb position peaked at $4.86M in Q3 2017.
1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Patriot Wealth Management's 13F filing for Q1 2018, filed 19 Apr 2018.